Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash	$ 37,163	$ 39,744
Accounts receivable	41	17
Prepaid expenses, deposits, and other current assets	5,923	4,165
Total current assets	43,127	43,926
Fixed assets, net	2,028	2,451
Operating lease right-of-use assets	5,014	3,037
Intangible assets, net	2,435	3,445
Other assets	1,079	1,121
Total assets	53,683	53,980
Current liabilities:
Accounts payable	1,162	2,704
Accrued expenses and other current liabilities	4,946	3,705
Operating lease liabilities, current portion	1,427	1,141
Senior Secured Convertible Notes - at fair value	42,990	33,650
Derivative liability - at fair value	260
Total current liabilities	50,785	41,200
Operating lease liabilities, less current portion	3,728	1,846
Total liabilities	54,513	43,046
Commitments and contingencies (Note 9)
Stockholders’ Equity:
Preferred stock, $0.001 par value. Authorized, 20,000,000 shares; Series B Convertible Preferred Stock, par value $0.001, issued and outstanding 1,254,497 at June 30, 2023 and 1,205,759 shares at December 31, 2022	2,841	2,695
Common stock, $0.001 par value. Authorized, 250,000,000 shares; 108,537,994 and 94,510,537 shares outstanding as of June 30, 2023 and December 31, 2022, respectively	109	95
Additional paid-in capital	226,321	216,106
Accumulated deficit	(260,783)	(228,169)
Treasury stock		(408)
Total PAVmed Inc. Stockholders’ Equity	(31,512)	(9,681)
Noncontrolling interests	30,682	20,615
Total Stockholders’ Equity	(830)	10,934
Total Liabilities and Stockholders’ Equity	$ 53,683	$ 53,980